How Is Rheumatoid Arthritis Diagnosed? Exams & Blood Tests

Rheumatoid arthritis (RA) is diagnosed through a combination of physical examination, blood tests, and sometimes imaging, with no single test that confirms it on its own. A widely used scoring system requires at least 6 out of 10 points across four categories: joint involvement, antibody levels, inflammation markers, and symptom duration. Because early treatment significantly improves outcomes, the diagnostic process is designed to identify RA before permanent joint damage occurs.

What Doctors Look for During a Physical Exam

The first step is a hands-on assessment of your joints. RA typically starts in the small joints of the hands and feet, particularly the knuckles closest to the palm, the middle finger joints, the wrists, and the joints at the base of the toes. A rheumatologist will press on and flex these joints to check for swelling, warmth, and tenderness, all signs of active inflammation in the joint lining.

Symmetrical swelling, where the same joints on both sides of the body are affected, is a hallmark of RA that has been present for some time. But early on, when only a few joints are involved, the pattern may not be symmetrical. That alone doesn’t rule out RA. Your doctor will also ask how long you’ve had symptoms. Joint pain, swelling, and stiffness lasting six weeks or longer is a key threshold in the diagnostic criteria, separating RA from short-lived viral or reactive joint inflammation.

Blood Tests That Help Confirm the Diagnosis

Two types of antibodies are central to diagnosing RA: rheumatoid factor (RF) and anti-CCP antibodies (also called ACPA). About 80% of people with RA test positive for one or both. Each test has different strengths. RF picks up about 92% of RA cases but also shows up in people with other conditions, meaning it produces more false positives. Anti-CCP is nearly as sensitive (88%) but far more specific (90%), so a positive result is a stronger signal that RA, rather than something else, is the cause.

Testing positive at high levels, defined as more than three times the upper limit of normal, carries more diagnostic weight than a low positive result. In the scoring system, a high-positive RF or anti-CCP earns 3 out of a possible 10 points, while a low positive earns 2. A negative result on both tests scores zero, but it doesn’t eliminate RA as a possibility.

Inflammation Markers: ESR and CRP

Two additional blood tests measure general inflammation in the body. The erythrocyte sedimentation rate (ESR, or “sed rate”) and C-reactive protein (CRP) both rise when inflammation is active. People with RA commonly have elevated levels of one or both. In severely active disease, an ESR of 50 to 80 is not unusual. An abnormal result on either test adds 1 point to the diagnostic score.

Normal inflammation markers in someone with joint symptoms are uncommon in untreated RA and should prompt your doctor to consider other explanations. That said, normal levels don’t completely rule it out.

How the Scoring System Works

The classification system used by rheumatologists scores four domains, and you need a total of 6 or more points out of 10 to be classified as having definite RA:

  • Joint involvement (0 to 5 points): A single large joint scores 0. Two to ten large joints scores 1. One to three small joints scores 2. Four to ten small joints scores 3. More than ten joints, with at least one small joint, scores the maximum 5.
  • Serology (0 to 3 points): Negative RF and anti-CCP scores 0. A low positive on either scores 2. A high positive on either scores 3.
  • Inflammation markers (0 to 1 point): Normal ESR and CRP scores 0. An abnormal result on either scores 1.
  • Symptom duration (0 to 1 point): Less than six weeks scores 0. Six weeks or longer scores 1.

The system requires confirmed swelling in at least one joint and no other diagnosis that better explains the symptoms. If you score below 6 today, that doesn’t mean the diagnosis is off the table permanently. You can be reassessed later as symptoms evolve.

When Imaging Comes Into Play

Standard X-rays can reveal bone erosions and joint space narrowing, but these changes often don’t appear until RA has been active for months or years. For early detection, MRI and ultrasound are far more useful.

MRI can detect three early signs of RA that X-rays miss. The first is synovitis, visible as thickening of the joint lining that lights up after contrast dye is injected. The second is bone erosions, which appear as sharply outlined areas of bone loss with breaks in the outer bone surface. The third is bone marrow edema, a pattern of fluid buildup inside the bone near where the joint lining attaches. This finding is particularly significant because it often predicts where erosions will develop later.

Ultrasound offers a faster, less expensive alternative. It can detect abnormal tissue inside the joint and show increased blood flow to inflamed areas using Doppler imaging. It also picks up bone erosions visible as breaks in the bone surface. One limitation: ultrasound cannot detect bone marrow edema, which only MRI can reveal.

What Happens if Your Antibody Tests Are Negative

Roughly 20% of people with RA test negative for both RF and anti-CCP antibodies. This is called seronegative RA, and it can be harder to diagnose because it removes 2 to 3 points from the scoring system. Diagnosis then leans more heavily on the number of affected joints, elevated inflammation markers, symptom duration, and imaging findings.

If you have persistent joint swelling in multiple small joints for six weeks or more, with elevated ESR or CRP, the point total can still reach 6 even without positive antibody tests. A person with more than ten affected joints (5 points), abnormal inflammation markers (1 point), and symptoms lasting over six weeks (1 point) would score 7, well above the threshold.

Ruling Out Other Conditions

Part of diagnosing RA involves making sure another condition isn’t responsible for the joint inflammation. Several conditions mimic RA closely, and the distinctions matter because treatments differ.

Psoriatic arthritis is one of the most common lookalikes. It tends to affect joints asymmetrically rather than symmetrically, and patients are usually negative for RF and anti-CCP. Swelling of an entire finger or toe (dactylitis) occurs in up to 50% of psoriatic arthritis cases but only about 5% of RA. Inflammation where tendons attach to bone (enthesitis) affects 35% of people with psoriatic arthritis and is uncommon in RA. Skin psoriasis precedes joint symptoms in 84% of psoriatic arthritis cases, and nail changes like pitting or lifting are a strong differentiator.

On imaging, the two conditions look different as well. RA causes bone erosions without new bone growth, while psoriatic arthritis often shows both erosion and new bone formation. The location of bone marrow edema on MRI also differs: near the joint capsule in RA, near tendon attachment points in psoriatic arthritis. Psoriatic arthritis patients also tend to have lower CRP and ESR levels than RA patients on average.

Other conditions your doctor may consider include lupus, gout, viral arthritis, and osteoarthritis. Each has distinguishing features in blood work, joint pattern, or imaging that help narrow the diagnosis.